Safety Assessment of Ubiquinol Acetate: Subchronic Toxicity and Genotoxicity Studies

Table 3

Dose confirmation & homogeneity analysis.

Day of Dose Formulation used for administration	% Recovery of analysed concentration
	(Dose Confirmation)
	Low dose			Mid dose			High dose
	(37.5 mg/mL)			(75.0 mg/mL)			(150.0 mg/mL)
Day 0	104.15			104.28			101.31
Day 49	96.74			97.58			98.10
Day 90	94.94			95.62			95.68
Day of Dose Formulation used for administration	% Recovery of analysed concentration
	(Homogeneity)
	Low dose			Mid dose			High dose
	(37.5 mg/mL)			(75.0 mg/mL)			(150.0 mg/mL)
	Top	Middle	Bottom	Top	Middle	Bottom	Top	Middle	Bottom
Day 0	102.32	103.30	103.39	103.40	104.42	104.84	106.28	107.59	105.63
Day 49	98.07	97.82	96.33	98.42	98.88	98.61	98.68	99.70	98.87
Day 90	96.06	96.11	93.87	96.19	96.86	97.11	97.57	96.78	96.56

Note: acceptable limits of % recovery: from 85 to 115 %.